LYMPHOMA, PRIMARY EFFUSION

Clinical trials for LYMPHOMA, PRIMARY EFFUSION explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, PRIMARY EFFUSION trials appear

Sign up with your email to follow new studies for LYMPHOMA, PRIMARY EFFUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat cancers: experimental drug trial targets rare lymphomas

Disease control Recruiting now

This study is testing an experimental drug called daratumumab for people with rare, aggressive types of lymphoma that have come back or haven't responded to standard treatments. The drug is given as a simple injection under the skin. Researchers want to see if it can help control…

Matched conditions: LYMPHOMA, PRIMARY EFFUSION

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

LYMPHOMA, PRIMARY EFFUSION

Get alerted when new LYMPHOMA, PRIMARY EFFUSION trials appear

New hope for Tough-to-Treat cancers: experimental drug trial targets rare lymphomas